Cargando…
Immunotherapy of Cancer: Developments and Reference Points, an Unorthodox Approach
Oncology is currently a sector of medical science with accelerated progress due to rapid technological development, the advancement in molecular biology, and the invention of many innovative therapies. Immunotherapy partially accounts for this advance, since it is increasingly playing an important r...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242802/ https://www.ncbi.nlm.nih.gov/pubmed/30791740 http://dx.doi.org/10.1177/1534735419827090 |
_version_ | 1783537302134325248 |
---|---|
author | Nikolaou, Michail Nikolaou, Georgios Digklia, Antonia Pontas, Christos Tsoukalas, Nikolaos Kyrgias, George Tolia, Maria |
author_facet | Nikolaou, Michail Nikolaou, Georgios Digklia, Antonia Pontas, Christos Tsoukalas, Nikolaos Kyrgias, George Tolia, Maria |
author_sort | Nikolaou, Michail |
collection | PubMed |
description | Oncology is currently a sector of medical science with accelerated progress due to rapid technological development, the advancement in molecular biology, and the invention of many innovative therapies. Immunotherapy partially accounts for this advance, since it is increasingly playing an important role in the treatment of cancer patients, bringing on a sense of hope and optimism through a series of clinical studies and cases with spectacular results. Immunotherapy, after the initial successes it experienced in the early 20th century, was forgotten after chemotherapy and radiotherapy prevailed and developed slowly in the background. Today, it is the new hope for cancer treatment, despite the unorthodox path it has followed. In this article, we study the course and key points of the discovery of immune-oncology from the oncologist’s point of view. We also record the questions that have been posed about immunotherapy that sometimes lead to confusion or stalemate. |
format | Online Article Text |
id | pubmed-7242802 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-72428022020-06-03 Immunotherapy of Cancer: Developments and Reference Points, an Unorthodox Approach Nikolaou, Michail Nikolaou, Georgios Digklia, Antonia Pontas, Christos Tsoukalas, Nikolaos Kyrgias, George Tolia, Maria Integr Cancer Ther Review Article Oncology is currently a sector of medical science with accelerated progress due to rapid technological development, the advancement in molecular biology, and the invention of many innovative therapies. Immunotherapy partially accounts for this advance, since it is increasingly playing an important role in the treatment of cancer patients, bringing on a sense of hope and optimism through a series of clinical studies and cases with spectacular results. Immunotherapy, after the initial successes it experienced in the early 20th century, was forgotten after chemotherapy and radiotherapy prevailed and developed slowly in the background. Today, it is the new hope for cancer treatment, despite the unorthodox path it has followed. In this article, we study the course and key points of the discovery of immune-oncology from the oncologist’s point of view. We also record the questions that have been posed about immunotherapy that sometimes lead to confusion or stalemate. SAGE Publications 2019-01-30 /pmc/articles/PMC7242802/ /pubmed/30791740 http://dx.doi.org/10.1177/1534735419827090 Text en © The Author(s) 2019 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Review Article Nikolaou, Michail Nikolaou, Georgios Digklia, Antonia Pontas, Christos Tsoukalas, Nikolaos Kyrgias, George Tolia, Maria Immunotherapy of Cancer: Developments and Reference Points, an Unorthodox Approach |
title | Immunotherapy of Cancer: Developments and Reference Points, an
Unorthodox Approach |
title_full | Immunotherapy of Cancer: Developments and Reference Points, an
Unorthodox Approach |
title_fullStr | Immunotherapy of Cancer: Developments and Reference Points, an
Unorthodox Approach |
title_full_unstemmed | Immunotherapy of Cancer: Developments and Reference Points, an
Unorthodox Approach |
title_short | Immunotherapy of Cancer: Developments and Reference Points, an
Unorthodox Approach |
title_sort | immunotherapy of cancer: developments and reference points, an
unorthodox approach |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242802/ https://www.ncbi.nlm.nih.gov/pubmed/30791740 http://dx.doi.org/10.1177/1534735419827090 |
work_keys_str_mv | AT nikolaoumichail immunotherapyofcancerdevelopmentsandreferencepointsanunorthodoxapproach AT nikolaougeorgios immunotherapyofcancerdevelopmentsandreferencepointsanunorthodoxapproach AT digkliaantonia immunotherapyofcancerdevelopmentsandreferencepointsanunorthodoxapproach AT pontaschristos immunotherapyofcancerdevelopmentsandreferencepointsanunorthodoxapproach AT tsoukalasnikolaos immunotherapyofcancerdevelopmentsandreferencepointsanunorthodoxapproach AT kyrgiasgeorge immunotherapyofcancerdevelopmentsandreferencepointsanunorthodoxapproach AT toliamaria immunotherapyofcancerdevelopmentsandreferencepointsanunorthodoxapproach |